LUMO Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 geg. 2024 @ 23:00):

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders...

Stats
Dzisiejszy wolumen	270 526
Średni wolumen	19 686.00
Kapitalizacja rynkowa	24.48M
EPS	$0 ( 2024-05-01 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.720
ATR14	$0.0160 (0.53%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-04	Pitukcheewanont Pisit Duke	Sell	0	Common Stock
2023-06-01	Pitukcheewanont Pisit Duke	Sell	29 750	Stock Option (Right to Buy)
2024-02-01	Pitukcheewanont Pisit Duke	Sell	3 333	Stock Option (Right to Buy)
2024-07-01	Pitukcheewanont Pisit Duke	Sell	25 500	Stock Option (Right to Buy)
2023-08-01	Mckew John C.	Sell	1 593	Common Stock

INSIDER POWER
24.13
Last 99 transactions
Buy: 596 623 \| Sell: 145 033

Wolumen Korelacja

Długi: 0.00 (neutral)

Krótki: 0.94 (very strong)

Signal:(49.255) Expect same movement, but be aware

Lumos Pharma Inc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lumos Pharma Inc Korelacja - Waluta/Towar

-0.08
( neutral )

0.00
( neutral )

-0.32
( neutral )

0.16
( neutral )

Lumos Pharma Inc Finanse

Annual	2023
Przychody:	$2.05M
Zysk brutto:	$2.01M (97.85 %)
EPS:	$-4.18

FY	2023
Przychody:	$2.05M
Zysk brutto:	$2.01M (97.85 %)
EPS:	$-4.18

FY	2022
Przychody:	$1.52M
Zysk brutto:	$1.47M (96.78 %)
EPS:	$-3.71

FY	2021
Przychody:	$230.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.00365

Financial Reports:

No articles found.

Lumos Pharma Inc